Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRO350 in mild-to-moderate psoriasis
NCT06125808Phase 2Completed
- Sponsor
- Arctic Bioscience
- Start
- May 2023
- Primary completion
- Oct 2024
- Modality
- Liposomes, Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of HRO350 in psoriasis, sponsored by Arctic Bioscience. Started May 2023; status: completed.
02
Drugs
HRO350
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT06125808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06125808.